Preben Philip

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

J Pedersen-Bjergaard, Gedske Daugaard, Steen Werner Hansen et al. · The Lancet · 1991 · 367 citations

Medicine, Oncology, Chemotherapy +11

Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA- topoisomerase II

HJ Super, NR McCabe, MJ Thirman et al. · Blood · 1993 · 319 citations · Full text

Medicine, Molecular Genetics, Oncology +15

Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia

J Pedersen-Bjergaard, Michael Pedersen, Diane Roulston et al. · Blood · 1995 · 310 citations · Full text

Medicine, Genetics, Hematology +16

Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II [letter]

J Pedersen-Bjergaard, Preben Philip · Blood · 1991 · 206 citations · Full text

Life Sciences, Genetics, Oncology +16

Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.

J Pedersen-Bjergaard, Preben Philip, Larsen So et al. · PubMed · 1993 · 182 citations

Medicine, Hematology, Oncology +17